The Efficacy and Safety of Corticosteroids in Combination with Ruxolitinib and Traditional Chinese Medicine in the Treatment of Severe Immune Checkpoint Inhibitor-Associated Myocarditis

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2024
This article has no abstract
Epistemonikos ID: 3f1a7253936e4107a54132a83e135ab91f8597e9
First added on: Apr 08, 2025